Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial.

Saved in:

Bibliographic Details
Title:	Association of BDNF, HTR2A, TPH1, SLC6A4, and COMT polymorphisms with tDCS and escitalopram efficacy: ancillary analysis of a double-blind, placebo-controlled trial.
Authors:	Brunoni, Andre R.^1,2 brunowsky@gmail.com, Carracedo, Angel³, Amigo, Olalla M.³, Pellicer, Ana L.³, Talib, Leda², Carvalho, Andre F.⁴, Lotufo, Paulo A.¹, Benseñor, Isabela M.¹, Gattaz, Wagner², Cappi, Carolina⁵
Source:	Brazilian Journal of Psychiatry / Revista Brasileira de Psiquiatria. Mar/Apr2020, Vol. 42 Issue 2, p128-135. 8p.
Database:	Academic Search Ultimate

Description
ISSN:	15164446
DOI:	10.1590/1516-4446-2019-0620